Skip to content

Study on Acupoint Catgut Embedding Intervention on the Intestinal Flora of Female Patients with Abdominal Obesity

Study on Acupoint Catgut Embedding Intervention on the Intestinal Flora of Female Patients with Abdominal Obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048853
Enrollment
Unknown
Registered
2021-07-18
Start date
2021-07-19
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdominal obesity

Interventions

Sponsors

Yunnan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for abdominal obesity; 2. Females, aged from 18 to 40 years; 3. Have a certain writing and reading ability to understand the entire process of research; 4. Signed informed consent forms; 5. No other trials were taken within three months.

Exclusion criteria

Exclusion criteria: 1. Extramly obese patients (BMI>=40kg/m2); 2. Secondary obesity, such as obesity caused by endocrine disease (Cushing syndrome, thyroid disease, hypothalamic disease, pituitary disease, gonadal disease, etc.) and medication (glucocorticoid or antipsychotics); 3. Pregnancy, lactation, or who have fertility requirements or are unable to provide adequate contraception within the last 6 months; 4. Mental disorder, cardiovascular disease, liver and kidney impairment, immunodeficiency, diabetes, blood disease; 5. There has been a history of surgery for obesity; 6. Patients with symptoms of gastrointestinal system, such as active peptic ulcers/bleeding, or previous recurrent ulcers/bleeding; 7. Previously undergone major intestinal excision or gastrointestinal major surgery; 8. People who take antibiotics for 3 days or more in the last 3 months; 9. Patients with long-term dysmenorrhea; 10. People who tend to bleed, or who are allergic to alcohol or animal proteins.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;Body Mass Index;

Secondary

MeasureTime frame
weight;waistline;Visual analogue appetite scale;Gastrointestinal Symptoms Rating Scale;

Countries

China

Contacts

Public ContactGuo Taipin

Yunnan University of Chinese Medicine

gtphncs@126.com+86 18487272658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026